Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KORU Medical Systems, Inc.KRMD · Entity 6517 | Director | October 01, 2026 | October 01, 2026 |
| ViewRay, Inc.VRAY · Entity 111118 | Chief Operating Officer | March 01, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KORU Medical Systems, Inc.
Report date October 01, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 106,263 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 5,119 · Balance 106,263 |
ViewRay, Inc.
Report date March 01, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,675,308 |
Reported balance
After 2021-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-01 · Tax withholding · Disposed 13,174 · Balance 1,675,308 F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 1,589,687 |
Reported balance
After 2021-03-02 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-03-02 · Tax withholding · Disposed 85,621 · Balance 1,589,687 F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2: Includes 1,504,687 shares granted as RSUs. As of the transaction date, 475,441 of the RSUs have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Payment of tax liability by withholding securities incident to vesting of restricted stock units.
F2: Includes 1,504,687 shares granted as RSUs. As of the transaction date, 475,441 of the RSUs have vested.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPECTRANETICS CORP
Report date August 09, 2017 · Filed August 11, 2017
Section 16 reporting ended · disclosed 2017-08-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| SPNC Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 1
1 source rowRow 1 · 2017-08-09 · Disposition to issuer · Disposed 133,839 · Balance 0 F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes. F2: Includes 8,572 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.51 · Expires 2018-06-17 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-09 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.74 · Expires 2018-12-08 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-09 · Disposition to issuer · Disposed 41,245 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.76 · Expires 2020-06-01 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-09 · Disposition to issuer · Disposed 84,794 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.93 · Expires 2021-04-15 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-09 · Disposition to issuer · Disposed 10,937 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.44 · Expires 2023-07-10 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-09 · Disposition to issuer · Disposed 23,870 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.05 · Expires 2026-01-08 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-09 · Disposition to issuer · Disposed 80,540 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Stock Option (Righ to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.87 · Expires 2022-05-31 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-09 · Disposition to issuer · Disposed 31,476 · Balance 0 F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-09 · Disposition to issuer · Disposed 1,621 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-09 · Disposition to issuer · Disposed 8,436 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-08-09 · Disposition to issuer · Disposed 13,289 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-08-09 · Disposition to issuer · Disposed 18,824 · Balance 0 F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-08-09 · Disposition to issuer · Disposed 35,105 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
| Performance Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-09 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-08-09 · Disposition to issuer · Disposed 12,550 · Balance 0 F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the "Merger Agreement") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the shares described in Note 2 below was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes.
F2: Includes 8,572 shares of Company common stock underlying performance stock units that were subject solely to service-based vesting conditions immediately prior to the Effective Time (as defined in the Merger Agreement) and that, pursuant to their terms upon consummation of the Merger Agreement, were treated as restricted stock units and were cancelled at the Effective Time and converted into the right to receive $38.50 per share in cash, without interest and less any required withholding taxes.
F3: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes.
F4: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes.
F5: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 1, 2026 21:23 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,119 | $2.93 | $14,998.67 |
DisclosureSEC source: 0001161697-26-000224 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,263 Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 21:20 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,571 | $4.20 | $14,998.20 |
DisclosureSEC source: 0001161697-26-000149 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,144 Read SEC document |
| April 01, 2026 Filed Apr 1, 2026 20:48 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,472 | $4.32 | $14,999.04 |
DisclosureSEC source: 0001161697-26-000083 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,573 Read SEC document |
| January 02, 2026 Filed Jan 2, 2026 23:51 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 2,581 | $5.81 | $14,995.61 |
DisclosureSEC source: 0001161697-26-000012 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,101 Read SEC document |
| October 02, 2025 Filed Oct 2, 2025 20:39 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,916 | $3.83 | $14,998.28 |
DisclosureSEC source: 0001161697-25-000338 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,520 Read SEC document |
| July 02, 2025 Filed Jul 2, 2025 20:55 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,189 | $3.58 | $14,996.62 |
DisclosureSEC source: 0001161697-25-000203 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,604 Read SEC document |
| April 02, 2025 Filed Apr 2, 2025 20:30 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,870 | $2.56 | $15,027.20 |
DisclosureSEC source: 0001161697-25-000134 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,415 Read SEC document |
| January 03, 2025 Filed Jan 3, 2025 21:29 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,937 | $3.81 | $14,999.97 |
DisclosureSEC source: 0001161697-25-000021 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,545 Read SEC document |
| October 01, 2024 Filed Oct 1, 2024 20:05 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,454 | $2.75 | $14,998.50 |
DisclosureSEC source: 0001161697-24-000409 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,608 Read SEC document |
| July 11, 2024 Filed Jul 12, 2024 14:42 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,545 | $2.71 | $15,026.95 |
DisclosureSEC source: 0001161697-24-000309 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,154 Read SEC document |
| March 31, 2024 Filed Apr 1, 2024 20:12 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000172 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,609 Read SEC document |
| December 31, 2023 Filed Jan 2, 2024 21:52 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,329 | $2.37 | $14,999.73 |
DisclosureSEC source: 0001161697-24-000011 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,280 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:21 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,484 | $2.74 | $15,026.16 |
DisclosureSEC source: 0001161697-23-000520 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,744 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:15 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,310 | $3.48 | $14,998.80 |
DisclosureSEC source: 0001161697-23-000394 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,260 Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:07 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,521 | $4.26 | $14,999.46 |
DisclosureSEC source: 0001161697-23-000217 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,753 Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 20:08 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 3,521 | $4.26 | $14,999.46 |
DisclosureSEC source: 0001161697-23-000237 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,950 Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:52 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 4,273 | $3.51 | $14,998.23 |
DisclosureSEC source: 0001161697-23-000028 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,429 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:59 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,681 | $2.25 | $15,032.25 |
DisclosureSEC source: 0001161697-22-000497 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,156 Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 22:19 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 6,002 | $2.50 | $15,005.00 |
DisclosureSEC source: 0001161697-22-000342 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,475 Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 21:33 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,221 | $2.87 | $14,984.27 |
DisclosureSEC source: 0001161697-22-000165 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,473 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:27 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001161697-22-000016 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,252 Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 20:17 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-21-000474 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,617 Read SEC document |
| September 30, 2021 Filed Dec 27, 2021 21:58 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-21-000594 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,252 Read SEC document |
| September 30, 2021 Filed Dec 12, 2023 21:05 UTC Amendment | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 5,263 | $2.85 | $14,999.55 |
DisclosureSEC source: 0001161697-23-000606 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,459 Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 23:22 UTC | KORU Medical Systems, Inc. KRMD · Entity 6517 | GrantCommon Stock | 1,566 | $4.63 | $7,250.58 |
DisclosureSEC source: 0001161697-21-000336 · form_4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,989 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:22 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 85,621 | $4.51 | $386,150.71 |
DisclosureSEC source: 0001209191-21-017341 · doc4.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,589,687 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 1,504,687 shares granted as RSUs. As of the transaction date, 475,441 of the RSUs have vested. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:22 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 13,174 | $4.66 | $61,390.84 |
DisclosureSEC source: 0001209191-21-017341 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,675,308 F1 · shares: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 21:21 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 91,626 | $3.05 | $279,459.30 |
DisclosureSEC source: 0001209191-20-055938 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,688,482 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 1,603,482 shares granted as RSUs. As of the transaction date, 349,193 of the RSUs have vested. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:07 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 84,662 | $2.45 | $207,421.90 |
DisclosureSEC source: 0001209191-20-043625 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780,108 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. F2 · balance_after: Includes 1,695,108 shares granted as RSUs. As of the transaction date, 232,486 of the RSUs have vested. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 23:16 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 585,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015593 · doc4.xml · nonDerivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,864,770 F2 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of March 2, 2020, subject to the Reporting Person remaining a service provider through each such vesting date. F3 · balance_after: Includes 1,779,770 shares granted as RSUs. As of the transaction date, 124,648 of the RSUs have vested. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 23:16 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 13,198 | $2.87 | $37,878.26 |
DisclosureSEC source: 0001209191-20-015593 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,279,664 F1 · kind: Payment of tax liability by withholding securities incident to vesting of restricted stock units. Read SEC document |
| October 24, 2019 Filed Oct 28, 2019 20:57 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 625,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054260 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,292,862 F1 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of October 24, 2019, subject to the Reporting Person remaining a service provider through each such vesting date. F2 · balance_after: Includes 1,207,862 shares granted as RSUs. As of the transaction date, 107,838 of the RSUs have vested. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 20:21 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 60,000 | $4.02 | $241,200.00 |
DisclosureSEC source: 0001209191-19-046129 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,862 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.03, inclusive. The reporting person undertakes to provide to ViewRay, Inc., any security holder of ViewRay, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: Includes 582,862 shares granted as RSUs. As of the transaction date, 107,838 of the RSUs have vested. Read SEC document |
| July 22, 2019 Filed Aug 8, 2019 00:38 UTC | ViewRay, Inc. VRAY · Entity 111118 | Tax withholdingCommon Stock | 84,662 | $9.49 | $803,442.38 |
DisclosureSEC source: 0001209191-19-045048 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,862 F1 · shares: In connection with the vesting of shares of RSUs, ViewRay, Inc. (the "Issuer") withheld vested shares to satisfy tax withholding obligations. The number of vested shares withheld was based on the closing price per share on July 22, 2019. The withholding of vested shares pursuant to this award was approved by the Compensation Committee of the Board of Directors of the Issuer, and the number of shares indicated in this Form 4 was acquired as treasury stock by the Issuer. F2 · balance_after: Includes 582,862 shares granted as RSUs. As of the transaction date, 107,838 of the RSUs have vested. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantStock Option (right to buy) · Derivative | 157,022 | $0.00 Strike: $8.47 | $0.00 |
DisclosureSEC source: 0001209191-19-016590 · doc4.xml · derivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,022 Underlying: Common Stock · 157,022 shares Expires 2029-03-01 F1 · derivative.exercise_date: 1/48th of the shares subject to the option shall vest and become exercisable on each month after March 1, 2019 (the "Grant Date"), such that 100% of the shares subject to the option will be vested on the fourth anniversary of the Grant Date, subject to the reporting person remaining a service provider through each such vesting date. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:42 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 90,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016590 · doc4.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,524 Read SEC document |
| November 13, 2018 Filed Nov 14, 2018 00:04 UTC | ViewRay, Inc. VRAY · Entity 111118 | PurchaseCommon Stock | 25,000 | $6.47 | $161,750.00 |
DisclosureSEC source: 0000950103-18-013355 · dp98358_4-matin.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 602,500 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.43 to $6.47, inclusive. The reporting person undertakes to provide to ViewRay, Inc., any security holder of ViewRay Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 22, 2018 Filed Jul 25, 2018 00:04 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantStock Option (right to buy) · Derivative | 962,500 | $0.00 Strike: $9.66 | $0.00 |
DisclosureSEC source: 0000950103-18-008822 · ownership.xml · derivative · entry 2 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 962,500 Underlying: Common Stock · 962,500 shares Expires 2028-07-22 F2 · derivative.exercise_date: The shares subject to this stock option are subject to service-based vesting requirements. 25% of the shares subject to the option shall vest and become exercisable on the first anniversary of July 22, 2018 (the "Vesting Commencement Date"), and thereafter, the remainder of the reported securities vest in equal monthly increments over the following 36 months, such that 100% of the reported securities will be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| July 22, 2018 Filed Jul 25, 2018 00:04 UTC | ViewRay, Inc. VRAY · Entity 111118 | GrantCommon Stock | 577,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-18-008822 · ownership.xml · nonDerivative · entry 1 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,500 F1 · kind: A total of one-third of the shares subject to this grant become vested on each of the first three anniversaries of July 22, 2018, subject to the Reporting Person remaining a service provider through each such vesting date. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerPerformance Stock Units · Derivative | 12,550 | $38.50 Strike: $0.00 | $483,175.00 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 14 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,550 shares Expires not disclosed F5 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. F5 · derivative.expiration_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerPerformance Stock Units · Derivative | 35,105 | $38.50 Strike: $0.00 | $1,351,542.50 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 13 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,105 shares Expires not disclosed F5 · derivative.exercise_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. F5 · derivative.expiration_date: Per the terms of the Merger Agreement, each performance stock unit award (other than performance stock units described in Note 2 above) that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash equal to the product of (i) (A) for performance stock units granted in 2016, the number of shares of Company common stock subject to such Company performance stock unit (assuming that any applicable performance conditions were deemed to be achieved at 150% of the target performance level), and (B) for performance stock units granted in 2017, the number of shares of Company common stock subject to such performance stock units (assuming that any applicable performance conditions were deemed to be achieved at the target performance level) and (ii) $38.50, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerRestricted Stock Units · Derivative | 18,824 | $38.50 Strike: $0.00 | $724,724.00 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 12 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,824 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerRestricted Stock Units · Derivative | 13,289 | $38.50 Strike: $0.00 | $511,626.50 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 11 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,289 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerRestricted Stock Units · Derivative | 8,436 | $38.50 Strike: $0.00 | $324,786.00 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 10 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,436 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerRestricted Stock Units · Derivative | 1,621 | $38.50 Strike: $0.00 | $62,408.50 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 9 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,621 shares Expires not disclosed F4 · derivative.exercise_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. F4 · derivative.expiration_date: Per the terms of the Merger Agreement, each restricted stock unit award that was outstanding as of immediately prior to the Effective Time (as defined in the Merger Agreement), was cancelled and converted into the right to receive cash in amount equal to $38.50 per share in cash, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 80,540 | $23.45 Strike: $15.05 | $1,888,663.00 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 8 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,540 shares Expires 2026-01-08 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 23,870 | $20.06 Strike: $18.44 | $478,832.20 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 7 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,870 shares Expires 2023-07-10 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Righ to Buy) · Derivative | 31,476 | $28.63 Strike: $9.87 | $901,157.88 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 6 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,476 shares Expires 2022-05-31 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,937 | $33.57 Strike: $4.93 | $367,155.09 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 5 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,937 shares Expires 2021-04-15 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 14:36 UTC | SPECTRANETICS CORP SPNC · Entity 173862 | Disposition to issuerStock Option (Right to Buy) · Derivative | 84,794 | $32.74 Strike: $5.76 | $2,776,155.56 |
DisclosureSEC source: 0001179110-17-011365 · edgar.xml · derivative · entry 4 Matin Shahriar · CIK 0001396270 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,794 shares Expires 2020-06-01 F3 · derivative.exercise_date: Per the terms of the Merger Agreement, each stock option that was outstanding and unexercised as of immediately prior to the Effective Time (as defined in the Merger Agreement), whether or not vested, was cancelled and converted into the right to receive cash in an amount equal to the product of (i) the number of shares of Company common stock for which such stock option had not then been exercised and (ii) the excess, if any, of the 38.50 per share in cash over the exercise price per share of Company common stock subject to each such stock option, without interest and less any required withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.